COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia. (2022)
Attributed to:
COVID-19 Immunity - National Core Study (IMM-NCS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2022.05.001
PubMed Identifier: 35588735
Publication URI: http://europepmc.org/abstract/MED/35588735
Type: Journal Article/Review
Volume: 40
Parent Publication: Cancer cell
Issue: 6
ISSN: 1535-6108